Physical activity and health: the effect of GoldFit YMCA participation on brain, breathing and blood pressure regulation in older adult humans - a cross-sectional study.

Not Applicable

• Conditions: Cardiovascular disease; Cardiovascular - Coronary heart disease; Cardiovascular - Hypertension; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12622000046707
• Lead Sponsor: niversity of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-01-17
• Last Update Posted: 24 January 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Aged >60 years old
- Men and women
- Free of chronic cardiovascular, respiratory, metabolic, or neurological disease
- Classified as either:

Currently enrolled in the YMCA GoldFit exercise training programme OR have been regularly exercising (3
or more sessions/week) for >12 months, aged >60 years old;

Not been regularly exercising for >12 months, aged >60 years old

Exclusion Criteria

• BMI <18 kg/m2
• Current smoker
• Current users of recreational drugs
• Current abusers of alcohol
• Recent (<12 month) history of hospital admission
• Significant arrhythmias (e.g., atrial fibrillation, previous VT / significant ventricular ectopy)
• Hemodynamically significant valvular heart disease (e.g., stenosis, mechanical valve replacement)
• Severe left ventricular systolic dysfunction
• Recent acute coronary syndrome (<12 months) (e.g., MI, angioplasty, unstable angina)
• Previous coronary artery bypass surgery
• Secondary causes of hypertension (e.g., phaeochromocytoma)
• Recent stroke/TIA (<12 months)
• Inability to fully or appropriately provide consent (e.g., language issue, reading capability)
• Underlying medical conditions, which in the opinion of the Investigator place the participant at unacceptably high risk for participating in the study.
Chronic and systemic illness including:
• Severe respiratory disease (e.g., chronic obstructive pulmonary disease);
• Severe, uncontrolled type II diabetes;
• Current treatment for cancer or complete remission <5 years
• Connective tissue or inflammatory disease
• Neurological / psychiatric disease (e.g., peripheral neuropathy, dementia, Parkinson’s, epilepsy)
• Infection or pyrexial illness
• Uncontrolled thyroid disorders
• Renal impairment (e.g., eGFR <60)
• Liver disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified